Enovis (ENOV) Other Accumulated Expenses (2010 - 2011)

Enovis (ENOV) reported Other Accumulated Expenses of $80.4 million for Q4 2011, up 75.15% year-over-year from $45.9 million in Q4 2010, and up 26.97% quarter-over-quarter from $63.4 million in Q3 2011.

Enovis (ENOV) Other Accumulated Expenses (2010 - 2011) Analysis & Trends

Enovis (ENOV) has 2 years of Other Accumulated Expenses data on file, last reported at $80.4 million in Q4 2011.

  • Other Accumulated Expenses for Q4 2011 came in at $80.4 million, up 75.15% year-over-year; the trailing twelve-month figure through Dec 2011 was $80.4 million (up 75.15% YoY), and the FY2011 annual result was $80.4 million, up 75.15% from the prior year.
  • Other Accumulated Expenses improved to $80.4 million in Q4 2011 per ENOV's latest filing, from $63.4 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $80.4 million in Q4 2011 and troughed at $45.9 million in Q4 2010.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Enovis 1.26 Bn 1.23 Bn 365.49 Mn

Historic Data

Download Data
DateValue
Dec 31, 2011 80.44 Mn
Sep 30, 2011 63.35 Mn
Jul 1, 2011 50.03 Mn
Dec 31, 2010 45.93 Mn